News (97)

Transcript : Amylyx Pharmaceuticals, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 08:00 AM
Transcript : Amylyx Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 08:40 AM
Transcript : Amylyx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024
Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference BU
Transcript : Amylyx Pharmaceuticals, Inc. - Special Call
Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome BU
Amylyx Pharmaceuticals Announces Formal Intention to Remove RELYVRIO, ALBRIOZA from the Market, Provides Updates on Access to Therapy, Pipeline, Corporate Restructuring, and Strategy AQ
Amylyx Pharmaceuticals Announces Formal Intention to Remove RELYVRIO®/ALBRIOZA™ from the Market; Provides Updates on Access to Therapy, Pipeline, Corporate Restructuring, and Strategy BU
Transcript : Amylyx Pharmaceuticals, Inc. - Special Call
Transcript : Amylyx Pharmaceuticals, Inc., Q4 2023 Earnings Call, Feb 22, 2024
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results BU
Amylyx Pharmaceuticals Announces Completion of Enrollment in HELIOS, a Phase 2 Study of AMX0035 for the Treatment of Wolfram Syndrome BU
Amylyx Pharmaceuticals Announces Inducement Grants under Nasdaq Listing Rule 5635(4) AQ
Amylyx Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BU
Transcript : Amylyx Pharmaceuticals, Inc. Presents at The 6th Annual Evercore ISI HealthCONx Conference, Nov-28-2023 02:10 PM
Amylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as Chief Medical Officer BU
Amylyx Pharmaceuticals Appoints Camille L. Bedrosian as Chief Medical Officer CI
Transcript : Ultragenyx Pharmaceutical Inc. - Analyst/Investor Day
RHYTHM PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
ULTRAGENYX PHARMACEUTICAL INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) AQ
ULTRAGENYX PHARMACEUTICAL INC. : Change in Directors or Principal Officers (form 8-K) AQ
Ultragenyx Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President GL
Ultragenyx Pharmaceutical Inc. Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President CI
Transcript : Ultragenyx Pharmaceutical Inc., Q4 2022 Earnings Call, Feb 16, 2023
Transcript : Ultragenyx Pharmaceutical Inc., Q3 2022 Earnings Call, Nov 02, 2022
ULTRAGENYX PHARMACEUTICAL INC. : Change in Directors or Principal Officers (form 8-K) AQ
Transcript : Ultragenyx Pharmaceutical Inc., Q2 2022 Earnings Call, Jul 28, 2022
Transcript : Ultragenyx Pharmaceutical Inc. - Special Call
Transcript : Rhythm Pharmaceuticals, Inc. - Shareholder/Analyst Call
Transcript : Ultragenyx Pharmaceutical Inc. Presents at Bank of America 2022 Healthcare Conference, May-10-2022 02:40 PM
Transcript : Ultragenyx Pharmaceutical Inc., Q1 2022 Earnings Call, May 05, 2022
Ultragenyx to Participate at BofA Securities 2022 Healthcare Conference GL
Ultragenyx to Participate at BofA Securities 2022 Healthcare Conference GL
Mereo BioPharma : Our Partner Ultragenyx Announces First Patient Dosed in Pivotal Phase 2/3 Clinical Study of Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta PU
Mereo BioPharma : Our Partners Ultragenyx Announces First Patient Dosed in Pivotal Phase 2/3 Clinical Study of Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta PU
Ultragenyx Announces First Patient Dosed in Pivotal Phase 2/3 Clinical Study of Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta AQ
Transcript : Ultragenyx Pharmaceutical Inc., Q4 2021 Earnings Call, Feb 10, 2022
Ultragenyx Announces First Patient Dosed in Phase 1/2 Clinical Study of UX053, an mRNA Therapy for the Treatment of Glycogen Storage Disease Type III AQ
Transcript : Ultragenyx Pharmaceutical Inc., Q3 2021 Earnings Call, Nov 02, 2021
Transcript : Ultragenyx Pharmaceutical Inc., Q2 2021 Earnings Call, Aug 02, 2021
CRINETICS PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
Transcript : Rhythm Pharmaceuticals, Inc. - Shareholder/Analyst Call
Transcript : Ultragenyx Pharmaceutical Inc. Presents at BofA Securities 2021 Virtual Health Care Conference, May-12-2021 03:30 PM
Ultragenyx to Present at Bank of America Securities Healthcare Conference GL
Transcript : Ultragenyx Pharmaceutical Inc., Q1 2021 Earnings Call, May 04, 2021
123NextSee all

Companies (1)

CAMIL ALIMENTOS S.A. 575 M $
Logo Camil Alimentos S.A.

Camil Alimentos SA is a Brazil-based company primarily engaged in the food processing sector. The Company focuses on the manufacture and commercialization of rice, rice crackers, beans, peas, chickpeas and lentil seeds, soybean-based meals, popcorn, sugar ...


Insiders

Picture Camille Bedrosian
Camille Bedrosian

Dr. Camille L. Bedrosian, MD, is an Independent Director at Rhythm Pharmaceuticals, Inc., an Independent Director at Crinetics Pharmaceuticals, Inc., a Chief Medical Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc., a Member at American Society of Clinical Oncology, a Member at American Society of Hematology and a Member at American Society of Nephrology. She is on the Board of Directors at Rhythm Pharmaceuticals, Inc. and Crinetics Pharmaceuticals, Inc. Dr. Bedrosian was previously employed as a Chief Medical Officer & Senior Vice President by Alexion Pharmaceuticals, Inc., a Chief Medical Officer & Vice President by ARIAD Pharmaceuticals, Inc., a Senior Director-Oncology & Hematology by Genetics Institute, Inc., a Member by American Association for Cancer Research, a Member by American Association for the Advancement of Science, a Member by Duke Comprehensive Cancer Center, and an Assistant Professor by Duke University Medical Center. She received her undergraduate degree from Harvard University, a graduate degree from Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.


Picture Camille Jojo
Camille Jojo

Camille Jojo is currently working as the Executive Director & Head-Legal & Compliance at Techtronic Industries Co., Ltd.
Prior to this, Mr. Jojo worked as a Member at the Chartered Institute of Arbitrators (East Asia Branch) and as a Partner at Norton Rose Fulbright (Services) Ltd.
Mr. Jojo graduated from the University of Cardiff in 1977.


Picture Camille Burckhart
Camille Burckhart

Ms. Camille Burckhart is a Chief Information & Digital Officer, Executive VP at Popular, Inc. She is on the Board of Directors at Fundación Banco Popular, Inc. and Nuestra Escuela, Inc.


Picture Camille Bonnel
Camille Bonnel

Currently, Camille Bonnel is Head-Research at Tritax Big Box REIT Plc. In the past Ms. Bonnel was Research Analyst at Merrill Lynch International and Analyst at RBC Europe Ltd. (Broker).


Romain Camille Zaleski
Romain Camille Zaleski

Boss of the holding company Carlo Tassara International, Romain Zaleski is the eighth richest man in France according to the professional magazine Challenges. Arcelor shareholders with 7.8%, he holds 13% of French metals group Eramet, 2% stake in the insurer Generali and 3% stake in Vinci alongside another Baron, Francois Pinault.

Son of an intellectual Polish and a mother doctor, Romain Zaleski grew up in a famous family of the Polish aristocracy. In 1943, his father, who had joined the resistance is arrested in France before being deported to Buschenwald. A year later, it was his mother who was deported to Ravensbruck.

In 1951, Romain Zaleski accessit gets a diploma in math and physics, which opened the doors of Polytechnic in 1953. In 1958, he graduated from the famous Ecole Nationale Supérieure des Mines de Paris before joining the civil service. He worked in various ministries including the Ministry of Industry before leaving in 1972 for Revillon, a financial company where he worked for seven years.

During his consulting projects he did for Camilog, he visits the factory of steel Carlo Tassara that has cash flow problems.
Convinced that intelligent management would avoid the bankruptcy, he took the helm and he avoids bankruptcy. This successful experience encouraged him to invest in multiple companies specializing in steel and energy. In recent years, he is considered as a specialist of business rescue in peril.

In Italy, he has invested in many banks. He is a notable, especially since the day where he allowed EDF to get Montedison.
In 2005, His rigor and discretion allow him to be an intermediate in the transaction that allows the merger of Arcelor and Mittal.

In 2009, Romain Zaleski has seen his fortune reduced by over 60% becoming the fourth richest man in France.


Picture Gérard Rene Camille Deman
Gérard Rene Camille Deman

Currently, Gérard Rene Camille Deman occupies the position of Chairman & Chief Executive Officer for Drakkar Holdings SA and Chairman for Adisseo France SAS. He is also on the board of China National BlueStar (Group) Co., Ltd., Bluestar Adisseo Co. (former Chairman) and Bluestar Adisseo Nutrition Group Ltd. Mr. Deman previously occupied the position of Director-Manufacturing, Purchasing & Supply Chain at Aventis Animal Nutrition, Inc. and Vice President-Corporate Manufacturing at Solvay France SA.





Picture John C. Bedrosian
John C. Bedrosian

John C.
Bedrosian
is currently a Director at The International Dairy Foods Association, All Star Dairy Foods, Inc., and Dairy Institute of California.
He was formerly a Director at The American Institute of Baking and Vice President-Manufacturing at UNFI Grocers Distribution, Inc. Bedrosian obtained an undergraduate degree from The California State University.



Picture Zachary Bedrosian
Zachary Bedrosian

The founder of Bocks, Inc. is Zachary Bedrosian.
Mr. Bedrosian held the title of Director at Bocks, Inc.




Picture Geoffrey Bedrosian
Geoffrey Bedrosian

Mr. Bedrosian serves as the Chief Financial Office of Marcus & Millichap Company and is responsible for overseeing the entire finance function, including, capital markets, taxation, and treasury.
He also serves as a member of the Company's Investment Committee.
Mr. Bedrosian has significant experience within the real estate investment banking community and has acted as a strategic advisor to many private and public companies within the sector.
Prior to joining Marcus & Millichap Company, he was the Chief Financial Officer at Ramco-Gershenson Properties Trust, a publically-traded REIT, and served as the Managing Director in the Global Real Estate Investment Banking Group at Deutsche Bank Securities, Inc. Mr. Bedrosian earned a B.S.
in Finance and Administration from Mercy College and an M.S.
in Real Estate and Finance from New York University.




Picture Gregory R. Bedrosian
Gregory R. Bedrosian

Gregory R.
Bedrosian
is the founder of The Sputnik Group (1995) and Renaissance Capital KK (1995), where he held the title of Co-Partner.
He is also the founder of Redwood Capital Group LLC.
Currently, he holds the position of Chief Executive Officer & Director at Drake Star Partners Ltd., President, Co-Chief Executive Officer & Director at Drake Star Partners, Inc., Non-Executive Chairman of the Investment Committee at Da Vinci Capital Llc (since 2020), and Director at Redwood Capital (Europe) Ltd.
(since 1999).
In the past, he worked as a Principal at CSFB Private Equity Partners LLC (1992-1995) and at Inventures Ltd.





Picture Arthur P. Bedrosian
Arthur P. Bedrosian

Arthur P.
Bedrosian
served as the Chief Executive Officer & Director of Lannett Co., Inc. from 2014 to 2018.
Prior to that, he was the President & Chief Executive Officer of Trinity Laboratories, Inc. from 1999 to 2001.
He also served as the President & Chief Executive Officer of Kremers Urban Pharmaceuticals, Inc. Bedrosian received his undergraduate degree from Queens College and his graduate degree from Newport University.



Picture Brian G. Bedrosian
Brian G. Bedrosian

Brian G.
Bedrosian
currently works at iDevices LLC, as Director.



Picture Camille Johnston
Camille Johnston

Camille Johnston currently works at Ford's Theatre Society, as Vice Chairman from 2004 and Siemens Foundation, as Director from 2017.
Ms. Johnston also formerly worked at Rodale, Inc., as Vice President-Communications and Fox BSB Holdco, Inc., as Senior Vice President-Communications from 2005 to 2010.
Ms. Johnston received her graduate degree from the University of California, Los Angeles.



Picture Camille P. Julmy
Camille P. Julmy

Camille P.
Julmy
is the founder and Vice Chairman of US Equities Realty LLC, which was founded in 1978.
He currently holds the position of Vice Chairman at CBRE, Inc. and is also the Executive Director at United Nations Children's Fund.
Additionally, he serves as a Director at The Magnificent Mile Association and is a Member of The Executives Club of Chicago.
Mr. Julmy completed his undergraduate degree at the University of Fribourg.












Picture Camille Thiéry
Camille Thiéry

Camille Thiéry is currently the Chairman at Beh SASU, Chairman at F.I.A Partners SAS, and Director at Concept MultiMédia Switzerland SA. In the past, he held positions as Chairman at Beh Holding, Independent Director at Spir Communication SA, Director at 20 Minutes France SAS, and Director at Immofrabel.




Picture Camille Coiffet
Camille Coiffet

Camille Coiffet is associated with three companies, BCI Navigation SA, BCI SA, and BCI Carto, where he holds the position of Director in each of them.





Picture Camille Belliveau
Camille Belliveau

Camille Belliveau is currently a Director at Soricimed Biopharma, Inc. He was previously a Director at the Certified General Accountants Association of Canada.



Picture Camille Suh
Camille Suh

Camille Suh worked as a Fund Manager & Analyst at Lazard Frères Gestion SAS starting in 2007.
Ms. Suh's current job is at Lazard Frères Gestion SAS as a Fund Manager & Analyst.



Picture Camille Tang
Camille Tang

Camille Tang is the founder of ConvenientPower HK Ltd., which was founded in 2006.
She held the title of President & Director at the company.
Currently, Ms. Tang is an Independent Non-Executive Director at Hero MotoCorp Ltd.
since 2021.
She is also a Director at the Asia America MultiTechnology Association (Pearl River Delta).
In the past, Ms. Tang worked as an Executive Director-Asia Pacific at UBS UK Properties Ltd., and as a Principal at Harvard University and HSBC Investment Bank Asia Ltd.
Ms. Tang holds an MBA from Harvard University and an undergraduate degree from Stanford University.









Picture Camille M. El-Amin
Camille M. El-Amin

Ms. Camille M.
El-Amin
is a VP of Institutional Client & Investor Relations at Ariel Investments LLC.
She joined the firm in July 2007 and is responsible for overseeing all portfolio related analytics efforts, as well as servicing institutional client, consultant and third party relationships.
She is on the Board of Directors of the Chicago Child Care Society, where she serves as Vice President.
Prior to joining the firm, she worked as a Banking Analyst at JPMorgan Private Bank.
She graduated summa cum laude with a BA in Economics from Spelman College.







Picture Camille Mastronardi
Camille Mastronardi

Camille Mastronardi is currently a Senior Vice President at Sterling & Sterling LLC since 2012.
She obtained an undergraduate degree from Montclair State University.















Picture Camille St-Hilaire
Camille St-Hilaire

Camille St-Hilaire served as an Independent Director at Lounor Exploration, Inc. and as a Director at Jardincap, Inc. St-Hilaire earned an undergraduate degree from the University of Montréal in 1972 and a doctorate degree from Corporation de l'École Polytechnique de Montréal in 1975.


Picture Camille Fohl
Camille Fohl

Camille Nicolas Fohl is currently the Chairman at Fortis Bank AS, BNP Paribas SA (Research Firm), Banque et Caisse d'Epargne de l'Etat, and SPUERKEESS Ré SA. In the past, he served as the Chief Executive Officer-Commercial Banking at Ageas NV.
He was also the Chairman-Supervisory Board at Fortis Bank Polska SA and BNP Paribas Bank Polska SA. Additionally, he was a Member-Supervisory Board at DAB Bank AG.
Mr. Fohl received his undergraduate degree from Katholieke Universiteit Leuven in 1979.






Picture Camille Codner
Camille Codner

Camille Codner has worked as a Manager at the Entertainment Community Fund since 2011.


Picture Camille Nicita
Camille Nicita

Camille Nicita is currently the Chief Executive Officer & Director at Human8.
Prior to this role, Camille was the Managing Director-North America & Managing Partner at Gongos, Inc. and a Member at the Council of American Survey Research Organizations.
Camille holds an MBA from Wayne State University (Michigan) and an undergraduate degree from the University of Michigan.




Picture Camille D. LaBarre
Camille D. LaBarre

Camille D.
LaBarre
is currently the Managing Director at Metropolitan Opera Association, Inc.


Picture Camille McDonald
Camille McDonald

Camille McDonald currently works as the President-Brand Development at Bath & Body Works LLC.


Picture Camille Chaix-Viros
Camille Chaix-Viros

Camille Chaix-Viros worked as an Economist at Nomura International Plc.


Picture Camille M. Signorino
Camille M. Signorino

Camille M.
Signorino
worked as a Junior Portfolio Manager at Blackfriars Asset Management Ltd.
from 2008 to 2010.




Picture Camille Hill
Camille Hill

Camille Hill currently works at Scottsdale Area Chamber of Commerce, as Director.






Picture Camille Brunel
Camille Brunel

Camille Brunel has worked as an Investment Director at 123 Investment Managers SA since 2015.


No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW